J & J
J&J to pay $181 million for Risperdal settlement
August 31, 2012Janssen Pharmaceuticals, a unit of Johnson & Johnson, will pay $181 million to settle charges that it marketed antipsychotic medications for medically unapproved purposes.
FDA warns J & J on insulin pumps
January 17, 2012Johnson & Johnson could face penalties for not reporting incidents where insulin pumps have failed, the Food and Drug Administration has warned.
